Intellia Therapeutics Inc (NASDAQ:NTLA)
| 55.91 Delayed Data As of Sep 30 |  +0.62 / +1.12%Today’s Change | 37.08 Today|||52-Week Range 143.92 | -52.71% Year-to-Date |
Institutional investors purchased a net $3.4 million shares of NTLA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 85.78% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Mutual fund holders | 54.55% |
| Other institutional | 31.23% |
| Individual stakeholders | 22.18% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 9/08/2022 | IRISH LIFE INVESTMENT MANAGERS L... Bought 3.4 Thousand shares of Intellia Therapeutics Inc |
| 7/29/2022 | LUNIS VERMÖGENSMANAGEMENT AG Bought 3.0 Thousand shares of Intellia Therapeutics Inc |
| 8/31/2022 | PURPOSE INVESTMENTS, INC. Bought 20.00 shares of Intellia Therapeutics Inc |
Top 10 Owners of Intellia Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 12.52% | 9,514,580 | 571,445,675 | +533,551 | +5.94% |
| The Vanguard Group, Inc. | 8.35% | 6,345,729 | 381,124,484 | +137,625 | +2.22% |
| BlackRock Fund Advisors | 6.73% | 5,114,771 | 307,193,146 | +198,390 | +4.04% |
| Fidelity Management & Research Co... | 4.34% | 3,301,204 | 198,270,312 | +508,813 | +18.22% |
| SSgA Funds Management, Inc. | 4.14% | 3,143,811 | 188,817,289 | +746,284 | +31.13% |
| Nikko Asset Management Americas, ... | 3.66% | 2,781,136 | 167,035,028 | -91,133 | -3.17% |
| Viking Global Investors LP | 2.93% | 2,228,383 | 133,836,683 | -240,377 | -9.74% |
| T. Rowe Price Associates, Inc. (I... | 2.69% | 2,047,331 | 122,962,700 | -172,540 | -7.77% |
| AllianceBernstein LP | 2.24% | 1,704,651 | 102,381,339 | -43,030 | -2.46% |
| Federated Global Investment Manag... | 1.87% | 1,418,300 | 85,183,098 | +798,700 | +128.91% |
Top 10 Mutual Funds Holding Intellia Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Innovation ETF | 8.06% | 6,126,151 | 367,936,629 | +53,992 | +0.89% |
| Nikko AM Global Umbrella Fund - A... | 3.11% | 2,360,401 | 141,765,684 | +52,226 | +2.26% |
| Vanguard Total Stock Market Index... | 2.69% | 2,043,472 | 122,730,928 | +5,410 | +0.27% |
| Vanguard Small Cap Index Fund | 2.28% | 1,731,236 | 103,978,034 | +2,408 | +0.14% |
| ARK Genomic Revolution ETF | 2.25% | 1,710,863 | 102,754,432 | -4,652 | -0.27% |
| SPDR S&P Biotech ETF | 2.19% | 1,665,531 | 100,031,792 | +24,894 | +1.52% |
| iShares Russell 2000 ETF | 2.17% | 1,652,665 | 99,259,060 | +8,866 | +0.54% |
| Vanguard Small Cap Growth Index F... | 1.35% | 1,026,236 | 61,635,734 | +7,998 | +0.79% |
| Federated Hermes Kaufmann Small C... | 1.30% | 987,000 | 59,279,220 | +507,000 | +105.63% |
| Vanguard Extended Market Index Fu... | 1.26% | 956,643 | 57,455,979 | -3,728 | -0.39% |